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ABSTRACT
Heteroimmunization of rabbits with an ethanolic extract of esophageal mucosa in-
corporating Freund adjuvant has been successful in eliciting pemphigus-like antibodies
as judged by the criterion of indirect immuriofluorescent (IF) staining of the inter-
cellular areas of stratified squamous epithelium. These antibodies were shown to be
autoantibodies by Virtue of the demonstration of positive in vitro IF staining reactions
with the antibody-producer's own tissues. Pemphigus-like antibodies were shown to be
tissue specific, and histologically and serologically indistinguishable from the inter-
cellular antibodies of human pemphigus.
Histologic studies of epidermal lesions taken at the onest of iso- and autoantibody
formation disclosed the presence of subepidermal-like bullae. Whether the etiology of
these lesions is related to the presence of pemphigus-like antibodies and/or to the
existence of basement membrane antibodies remains to be resolved.
Pemphigus and pemphigoid, two chronic
bullous skin diseases of man have been the sub-
ject of numerous investigations. A comprehen-
sive review summarizing these investigations
has recently appeared (1). These studies have
focused primarily on the possible diagnostic
and prognostic value of employing the adjunct
sensitivity and specificity of immunologic reac-
tions, i.e., immunofluorescence (IF), to the es-
tablished histopathologic characteristics of
these dermatoses as an aid in differentiating
pemphigus and pemphigoid from other bullous
diseases and from each other (2—4).
As previous studies (3, 5—8) have demon-
strated that there appears to be a direct rela-
tionship between the severity of pemphigus and
the titer of intercellular (IC) antibodies, the
question arose as to whether or not the char-
acteristic histopathologic changes in pemphigus
might be attributed in part to immunologic
phenomena.
Suitable means for the preparation of aque-
ous and ethanolic extracts of human, rhesus
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monkey and bovine esophageal mucosa con-
taining antigen(s) possessing both tissue and
serologic specificity for autoantibodies to the
IC substance of stratified squamous epithelium
have been developed (9—11). Further efforts
were concentrated on the ethanol soluble frac-
tion as preliminary studies (12) indicated that
the aqueous fractions contained numerous
serum proteins in addition to the IC anti-
gen (s).
Heteroimmunization of rabbits with an
ethanolic extract of bovine esophageal mucosa
incorporating Freund adjuvant resulted in the
formation of pemphigus-like antibodies yield-
ing indirect IF staining patterns of the IC areas
of stratified squamous epithelium indistinguish-
able from those of human pemphigus autoan-
tibodies (10, 11, 13). Initially, these appeared
as heteroantibodies, i.e., they reacted with only
bovine epithelium, however, upon continued
immunization, antibodies reactive with rabbit
epithelium appeared (13). Pemphigus-like an-
tibodies were shown to be autoantibodies by
the demonstration of positive in vitro reactions
with the antibody-producer's own tissues (13).
These antibodies were shown to be tissue
specific, and histologically and serologically in-
distinguishable from the IC autoantibodies of
pemphigus.
Similar studies have been reported on the
isolation and antigenicity of an "insoluble"
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fraction of rabbit esophageal mucosa capable
of eliciting acantholytic lesions in sensitized
rabbits whose skin had been treated with so-
dium lauryl suiphonate and solid CO2 (14, 15);
and recently on the antigens of rat and mouse
epidermis (16).
It has been demonstrated (17) that the oc-
currence of circulating antibodies is not neces-
sarily accompanied by corresponding tissue
damage. The present study was undertaken in
an attempt to evaluate the possible immuno-
pathogenicity of ethanolic extracts of esopha-
geal mucosa in relation to autoantibodies to the
IC substance of stratified squamous epithelium
and the characteristic histopathology of
pemphigus.
MATERIALS AND METHODS
Source and preparation of epithelial extracts.
Bovine esophagi were obtained from the local
slaughter house. The mucosal layer was removed
immediately upon acquisition of specimens. Sepa-
ration was accomplished by placing the esophagus,
mucosa side up, on a piece of aluminum foil cooled
from below by solid CO2 and by stripping the
mucosa from the underlying adventitia with the
aid of scalpel and scissors. Histologic examination
confirmed that only the epithelial layers were re-
moved. The mucosa was then extracted with 95 per
cent ethanol and dried in vacuo. Details of this
preparation appear elsewhere (11). The protein
concentration of ethanolic extracts of bovine
esophageal mucosa, hereafter referred to as BEM-
F5, ranged from 8—10 mg/mi protein/mi as deter-
mined by the biuret method of Gornall, Bardawili
and David (11).
Preparation of antisera. New Zealand Albino
rabbits weighing 4—5 lbs. were used for inoculation.
Procedures for inoculation were as described in a
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FIG. 1. Characteristic hetero- (.) and iso- and
autoantibody (0) response following inoculation
of rabbits with an ethanohc extract of bovine
esophageal mucosa incorporating Freund adjuvant.
previous paper (13). Essentially, BEM-F5, at a
concentration of 10 mg/mi was emulsified with an
equal volume of complete Freund adjuvant (Difco
Laboratories, Detroit, Michigan) for the first two
inoculations or incomplete Freund adjuvant (Difco
Laboratories, Detroit, Michigan) for subsequent
inoculations. Approximately 1.5 ml of emulsion was
injected intradermally into each animal in the
shaved skin of the back, using 10—12 sites for in-
jection. Twelve inoculations were administered at
14 day intervals for a period of approximately 8
months. Bleedings were obtained 7 days after each
inoculation.
To assess the possible specificity of any subse-
quent histologic changes as a result of inoculation
with ethanolic extracts of esophageal mucosa, two
additional groups of animals were used as controls.
The first group was inoculated with only complete
Freund adjuvant (Difco Laboratories, Detroit,
Michigan). In this group saline was used in place
of extract. A second group was inoculated with
complete Freund adjuvant (Difco Laboratories,
Detroit, Michigan) and an unrelated antigen.
Immuno fluorescent and specificity studies. In-
direct IF staining for the sensitivity and specificity
of sera were carried out by standard methods as
previously described (13). Briefly, tissues were
quick-frozen in liquid nitrogen, sectioned at 4
in a cryostat, treated (unfixed) with serial dilu-
tions of rabbit anti-BEM-F5 sera and a fluorescein
conjugated goat anti-rabbit IgG preparation with
an apparent F:P ratio of 1.3, used at '/4 unit of
anti-IgG/ml or approximately 1/jo mg antibody
protein/mi (for specifics regarding the methods of
conjugate preparation and standardization, see
reference 18).
In vivo binding nd histologic studies. Tissue
specimens for the possible detection of in vivo
binding of IgG and for histologic examination were
obtained by biopsy or at the time of autopsy from
all animals inoculated. Biopsies were taken after
local anaesthesia with 2 per cent xylocaine HC1
(Jansen-Saisbery Laboratories, Kansas City, Mo.).
Specimens to be examined for in vivo binding of
IgG were prepared as described above; treated
with a fluorescein conjugated goat anti-rabbit IgG
preparation, and examined for fluorescence. Speci-
mens for histologic study were fixed in formalde-
hyde solution (10% buffered Formalin), embedded
in paraffin and serially sectioned. The sections
were stained with haematoxylin and eosin and ex-
amined microscopically.
RESULTS
Figure 1 illustrates the characteristic anti-
body response following heteroimmunization of
rabbits with an ethanolic extract of bovine
esophageal mucosa incorporating Freund adju-
vant. Initially, pemphigus-like antibodies react-
ing only with bovine epithelium appeared
following 4 weeks of immunization. The onset
of pemphigus-like iso- and autoantibodies ap-
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FIGS. 2 and 3. Photomicrographs of indirect IF staining reactions obtained with epi-
thelium (skin and esophagus respectively) of the antibody-producer with a 1:20 dilution
of the animal's own serum, X 375.
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peared approximately 18 weeks later following
22 weeks of immunization. Figures 2 and 3
depict the typical IF staining patterns obtained
with sections of epithelium (skill and esopha-
gus respectively) of the antibody-producer. As
there appeared to be no consistency to the
scattered IF staining observed in the dermis of
skin biopsies as noted in Figure 2, this may be
at best attributed to non-specific fluorescence.
To evaluate the tissue specificity of pem-
phigus-like antibodies, rabbit antisera were ab-
sorbed with ethanolie extracts of bovine tissues
(esophageal mucosa, gastric mueosa, kidney,
liver and spleen). Only extracts of esophageal
mucosa bound the pemphigus-like antibodies
thereby inhibiting the IF staining for IC areas
of stratified squamous epithelium.
Indirect IF staining reactions of other rabbit
tissues (kidney, liver and spleen) with rabbit
antisera for the presence of antibodies other
than those to the IC areas of stratified squa-
mous epithelium were consistently negative.
The possibility that the observed IF staining
reactions were due to the presence of natural
haemagglutinins, or a consequence of hyperim-
munization with ethanol soluble blood group
antigens, was examined by absorption of
rabbit antisera with varying amounts of blood
group specific substances A and B (derived
from porcine and equine gastric mucosa). Prior
to use, blood group substances were tested by
haemagglutination, with at least three high
titered (>20,000) anti-A and anti-B blood
group sera for their capacity to bind anti-A
and anti-B antibodies. Absorption of rabbit an-
tisera with A and B substances, even at a ratio
of 9 parts A and B substances to 1 part serum
did not diminish the IF staining titer of
pemphigus-like antibodies.
Inoculated areas of rabbit epidermis were
marked by the appearance of irregularly
shaped "bullous-like" cutaneous lesions approx-
imately 2 to 3 centimeters in diameter. The
lesions were frequently situated on, and occa-
sionally surrounded by a highly edematous
area. The number of lesions varied from three
to seven; and were most often seen in groups
of two or three. Comparable cutaneous lesions
were not observed in two additional groups of
animals employed as controls. In this series,
three animals were inoculated with only com-
plete Freund adjuvant and saline, and three
were inoculated with complete Freund adju-
vant and liver extracts. Absence of cutaneous
damage comparable to that observed in those
animals inoculated with ethanolio extracts of
esophageal mueosa was further documented by
histologic studies of skin biopsies obtained
from this group. Animals exhibiting bullous-
like lesions had pemphigua-like autoantibodies
at IF staining titers ranging from 16 to 64.
No specific binding of IgG was conclusively
detected in the IC areas of stratified squamous
epithelium of skin taken by biopsy at the on-
set of iso- and autoantibody formation, at the
site of epidermal lesions or with normal skin,
nor with other biopsied tissue possessing
stratified squamous epithelium, e.g., oral mu-
eosa, of the immunized animals. Subsequent
biopsies were taken every 14 days for the re-
mainder of the inoculation schedule and at
the time of exsanguination.
Histologic studies of biopsies of rabbit epi-
dermal lesions initially taken at the onset of
iso- and autoantibody formation within an
area of approximately 10 sq. em. surrounding
the site of inoculation, disclosed the presence
of what appeared to be subepidermal-like
bullae (Fig. 4) in three of four animals inoc-
ulated with BEM-F5. Frequently, necrotic
epidermal cells which had become detached
were observed in the bulla cavity (Fig. 4).
Comparable histologic changes were not ob-
served in the epidermis of animals similarly
inoculated with complete Freund adjuvant
and/or other antigenic preparations (as de-
scribed above).
DIscussIoN
It has been demonstrated (10, 11, 13) that
immunization of rabbits with an ethanol solu-
ble extract of bovine esophageal mueosa moor-
orating Freund adjuvant was successful in
eliciting an antibody response as judged by the
criteria of indirect IF staining of the IC areas
of stratified squamous epithelium. The anti-
bodies elicited were found to stain the IC areas
of other tissues possessing stratified squamous
epithelium, e.g., oral mueosa, but did not stain
kidney, liver or spleen. Pemphigus-like anti-
bodies were shown to be autoantibodies, as a
positive reaction was obtained with the anti-
body producer's own tissue. Although pem-
phigus-like autoantibodies were present at rea-
sonably significant titers, no definitive evidence
for the in ViVO binding of IgG was observed with
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FIG. 4. Photomicrograph of biopsy of rabbit epidermal lesion taken following 22 weeks
of inoculation disclosing presence of subepidermal-like bulla. Note presence of detached
epidermal cells within bullous cavity. Hematoxylin and eosm, X 125.
biopsied or autopsied tissues. Pemphigus-like
antibodies were shown to be tissue specific;
and histologically and serologically indistin-
guishable from the antibodies of human pemphi-
gus.
As previously mentioned, numerous IF
studies of the sera of patients with active
pemphigus have revealed that there is a direct
relationship between the severity of pemphigus
and the titer of IC antibodies to the IC areas
of stratified squamous epithelium (3, 5—8).
Comparable IF studies of patients with bullous
pemphigoid reveal that the majority of
these individuals have antibodies to the base-
ment membrane area (4, 19). However, unlike
pemphigus, no definitive correlation between
the patient's clinical status and level (titer) of
basement membrane antibodies has yet been
demonstrated in pemphigoid (19).
It is of importance to note, that despite the
demonstration by IF (2, 4, 19), and mosl re-
cently by gel diffusion with pemphigus sera
(20, 21), of specific circulating antibodies in
these two chronic bullous diseases, the patho-
genic significance of such antibodies remains
unknown at present.
To date IC antibodies have only been identi-
fied in pemphigus sera. However, it is of in-
terest to note that pemphigus may sometimes
occur in association with other "immunologic"
disturbances. Notable of recent, are the reports
of the concurrence of pemphigus and myas-
thenia gravis (22, 23). At present, six such
cases are under study (24). In one case, the
patient was found to have not only pemphigus
erythematosus and myasthenia gravis but, also
a thymoma (23, 25). The patient's serum con-
tained intercellular antibodies, muscle striation
antibodies and antinuclear antibodies (23). in
addition, recent observations (26, 27) suggest
that some post burn sera may have comparable
reactivity to that of sera from patients with
pemphigus. The relevance of these recent ob-
servations remains to he determined.
Basement membrane antibodies have thus
far been demonstrated only in bullous pemphi-
goid scm. However, unpublished observations
(24) reveal the presence of in vivo bound IgG
in the basement membrane area of patients
with concurrent pemphigus erythematosus and
lupus erythematosus. In addition, three cases
of bullous pemphigoid with systemic lupus
S
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erythematosus are currently under investiga-
tion (28). Two of these patients possess both
basement membrane antibodies and antinu-
clear antibodies.
It may be thus noted that the concurrent as-
sociation of pemphigus and pemphigoid with
other "immunologic" disturbances, e.g., myas-
thenia gravis, pemphigus erythematosus, etc.,
may occur; and does so mere frequently than
would be expected by chance.
Results of the present study suggest that the
observed clinical and histologic changes in the
epithelium of animals inoculated with an
ethanolic extract of esophageal mucosa are of
an immunologic nature. IF studies for the de-
tection of basement membrane antibodies in
the serum of rabbits possessing cutaneous le-
sions which appear to be similar from a clinical
and histological point of view to those seen in
bullous pemphigoid are presently in progress.
The in viva fixation of both IgG and comple-
ment in the epithelium of patients with pem-
phigus are suggestive to some degree of a patho-
genic effect of the autoantibodies in the IC
areas (29). Whether the mechanism(s) of the
clinical and histologic changes observed in the
present study is related to the presence of IC
antibodies and/or to the possible presence of
yet undetected basement membrane antibodies
remains to be determined.
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